BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25649722)

  • 1. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
    Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
    Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
    Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
    Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
    Cuna A; Lewis T; Dai H; Nyp M; Truog WE
    Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Wilson-Costello D; Walsh MC; Langer JC; Guillet R; Laptook AR; Stoll BJ; Shankaran S; Finer NN; Van Meurs KP; Engle WA; Das A;
    Pediatrics; 2009 Mar; 123(3):e430-7. PubMed ID: 19204058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB;
    JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes.
    Harmon HM; Jensen EA; Tan S; Chaudhary AS; Slaughter JL; Bell EF; Wyckoff MH; Hensman AM; Sokol GM; DeMauro SB;
    J Perinatol; 2020 Apr; 40(4):616-627. PubMed ID: 32020038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
    Onland W; Offringa M; De Jaegere AP; van Kaam AH
    Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL; Patterson CC; Halahakoon CW;
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage.
    Calisici E; Eras Z; Oncel MY; Oguz SS; Gokce İK; Dilmen U
    J Matern Fetal Neonatal Med; 2015; 28(17):2115-20. PubMed ID: 25354288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
    Thomas SR; Jain SK; Murthy P; Joseph CJ; Soraisham A; Tang S; Dosani A; Lodha A
    Am J Perinatol; 2024 May; 41(S 01):e2505-e2513. PubMed ID: 37399847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Neurodevelopmental Impairment in Bronchopulmonary Dysplasia.
    Bauer SE; Schneider L; Lynch SK; Malleske DT; Shepherd EG; Nelin LD
    J Pediatr; 2020 Mar; 218():22-27.e2. PubMed ID: 31926665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates.
    Kelly EN; Shah VS; Levenbach J; Vincer M; DaSilva O; Shah PS;
    J Matern Fetal Neonatal Med; 2018 Oct; 31(20):2665-2672. PubMed ID: 28714339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL; Mettelman BB; Bode MM; Gross SJ
    J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.